NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-275-2011-0-US-01 Tests and Treatment US 61/529,531 Abandoned
NIA E-103-2011-1-US-01 Use of Zscan4 And ZScan4-Dependent Genes For Direct Reprogramming Of Somatic Cells US 61/529,055 Abandoned
NCI E-104-2009-0-JP-05 MicroRNAs in Never-Smokers and Related Materials and Methods JP National Stage 2011-552098 Abandoned
NCI E-025-2011-1-US-01 Antibodies To Tumor Endothelial Marker 8 US 61/527,339 Abandoned
CC E-064-2010-0-JP-05 METHOD, SYSTEM AND DEVICES FOR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) PROCEDURES JP National Stage 2011-550675 Issued
NCI E-104-2009-0-US-07 MicroRNAs in Never-Smokers and Related Materials and Methods US National Stage 13/202,666 Abandoned
NCI E-065-2005-4-US-04 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES US National Stage 13/202,382 9120774 Abandoned PDF
NCI E-065-2005-4-JP-03 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES JP National Stage 2011-551248 Abandoned
NCI E-251-2011-0-US-01 Gene Expression Predictors of Tumor Responsiveness To Therapy US 61/525,539 Abandoned
NIA E-219-2008-0-US-03 Method for The Diagnosis Of Age-Associated Vascular Disorders US National Stage 13/202,319 Abandoned
NCI E-151-2011-0-US-01 Reduction of TGF-beta Signaling In Myeloid Cells In The Treatment of Cancer US 61/525,025 Abandoned
NCI E-250-2008-0-US-04 Quantitative Oxygen Imaging Systems And Methods Using Echo-based Single Point Imaging US National Stage 13/131,165 8712499 Issued PDF
NIMH E-054-2009-0-US-06 Phosphatidylinositol-3-Kinase P110 Delta-Targeted Drugs In The Treatments Of CNS Disorders US National Stage 13/132,425 Abandoned
NCI E-289-2011-0-US-01 The Ability Of Novel Yeast-MUC1 Constructs To Mature Human Dendritic Cells (DCs) And Activate Human T Cells US 61/524,407 Abandoned
NCATS E-038-2011-0-US-01 Small Molecule Treatment of Ataxia-Telangiectasia or DNA Damage US 61/524,177 Abandoned
NCI E-228-2010-0-AU-03 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations AU National Stage 2011292248 Abandoned
NCI E-228-2010-0-PCT-02 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations. PCT PCT PCT/US11/47719 Expired
NCI E-228-2010-0-EP-05 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations EP National Stage 11746738.1 Abandoned
NCI E-228-2010-0-CA-04 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations. CA National Stage 2809255 Abandoned
NIDCR E-063-2009-0-US-03 Serological Screening For HHV-8 Infection Using Antigen Mixtures US National Stage 13/201,317 8951723 Issued PDF
NICHD E-168-2009-0-US-01 Spin Echo Sequences For Diffusion Weighted Imaging of Moving Media US 61/523,108 Abandoned
NIAID E-124-2009-0-JP-05 Influenza Hemagglutinin And Neuraminidase Variants JP National Stage 2011-550155 Abandoned
NCI E-249-2010-0-PCT-02 Compounds With MDR1-Inverse Activity PCT PCT PCT/US2011/047377 Expired
NCI E-033-2011-0-US-02 METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN US ORD 13/207,856 Abandoned
NICHD E-273-2010-0-US-01 Methods For Characterizing Compartment Size Distributions From Magnetic Resonance Data US 61/522,421 Abandoned
NCI E-023-2009-0-US-03 Molecular-Based Method of Cancer Diagnosis And Prognosis US National Stage 13/148,851 8715928 Issued PDF
NIAID E-213-2011-0-US-01 Neutralizing Antibodies To HIV-1 And Their Use US 61/522,205 Abandoned
NIAID E-202-2011-1-US-01 PROTEASE-DEFICIENT BACILLUS ANTHRACIS US 61/521,617 Abandoned
NCI E-104-2009-0-CN-06 MicroRNAs in Never-Smokers and Related Materials and Methods CN National Stage 201080014309.6 Abandoned
NCI E-234-2010-1-EP-05 Biomarkers For Prostate Cancer And Methods For Their Detection EP National Stage 11749629.9 Abandoned
NCI E-234-2010-1-AU-03 Biomarkers For Prostate Cancer And Methods For Their Detection AU National Stage 2011285534 Abandoned
NCI E-234-2010-1-PCT-02 Biomarkers For Prostate Cancer And Methods For Their Detection. PCT PCT PCT/US2011/046799 Expired
NCI E-234-2010-1-EP-09 Biomarkers For Prostate Cancer And Methods For Their Detection EP DIV 16199473.6 Abandoned
NHGRI E-223-2011-0-US-01 Anti-Cancer Therapy Sensitivity-Related ATAD5 Activity and Products and Methods Related Thereto US 61/515,773 Abandoned
NIAID E-292-2010-1-US-01 NOVEL HIV-1 BROADLY NEUTRALIZING ANTIBODIES US 61/515,528 Abandoned
NCI E-234-2010-1-CA-04 Biomarkers For Prostate Cancer And Methods For Their Detection CA National Stage 2807514 Abandoned
NIAID E-189-2011-1-US-01 Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance US 61/515,237 Abandoned
NIAID E-189-2011-0-US-01 Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance US 61/515,229 Abandoned
NCI E-300-2001-0-US-05 New Tumor Suppressor Gene, p28ING5 US DIV 13/197,595 Abandoned
NCI E-042-2006-4-US-06 Variants In Complement Regulatory Genes Predict Age-related Macular Degeneration US CON 13/196,121 9063139 Abandoned PDF
NIAID E-202-2011-0-US-01 Protease-Deficient Bacillus Anthracis US 61/514,384 Abandoned
NCI E-188-1996-0-JP-09 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME JP DIV 2011-168822 Abandoned
NCI E-153-2009-0-US-04 Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection US National Stage 12/441,335 9334522 Issued PDF
NCCIH E-148-2010-0-PCT-02 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones PCT PCT PCT/US2011/045898 Expired
NCI E-130-2006-0-US-04 Methods And Systems For Purifying, Transferring, And/Or Manipulating Nucleic Acids US National Stage 13/147,167 Abandoned
NCCIH E-148-2010-0-IN-06 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones IN National Stage 1665/DELNP/2013 Abandoned
NCCIH E-148-2010-0-EP-05 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones EP National Stage 11813251.3 Abandoned
NCCIH E-148-2010-0-CA-04 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones CA National Stage 2807006 Abandoned
NCCIH E-148-2010-0-AU-03 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones (AU) AU National Stage 2011282511 Abandoned
NCI E-171-2011-0-US-01 Use of DPEP1 Expression Prognosis Of Pancreatic Ductal Adenocarcinoma US 61/512,302 Abandoned